Twist Bioscience Announces Microsoft Purchase Of Its Synthetic DNA For Digital Data Storage Research
Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, today announced Microsoft Corp. has agreed to purchase ten million long oligonucleotides from Twist Bioscience to encode digital data.
Anomali, the provider of the market-leading ThreatStream threat intelligence and Anomali Enterprise platforms, today announced it has raised $30 million in series C funding. The round, led by Institutional Venture Partners (IVP), includes significant investments from General Catalyst Partners, GV (formerly Google Ventures) and Paladin Capital Group.
Bugcrowd Raises $15 Million to Bring its Bug Bounty Security Platform to More Companies Around the Globe
Bugcrowd, Inc., the pioneer and innovator in crowdsourced security for the enterprise, today announced it has closed $15 million in a Series B funding round led by Blackbird Ventures. Existing investors Rally Ventures, Industry Ventures, Costanoa Venture Capital and Paladin Capital Group participated in the round, and were joined by new investor Salesforce Ventures.
Paladin Capital Announces Funding for Research into the Motivations of Young People to Become Cybercriminals
Paladin Capital Group, a Washington DC based private equity firm specialising in cyber security, announces today at Europol’s EC3 Academic Advisory Network Annual Conference that it is funding a research project called “Young People and Pathways into CyberCrime”. The research will be provided by high profile academics from Middlesex London University, Hawaii Pacific University and University College Dublin and supported by Europol’s EC3
Blockchain intelligence firm Elliptic today announced a $5 million Series A funding round led by Paladin Capital Group, with participation from Santander InnoVentures, KRW Schindler, Digital Currency Group, and existing investor, Octopus Ventures. Christopher Steed, Managing Director of Paladin Capital Group, will join Elliptic’s board of directors alongside Octopus Ventures, and Santander InnoVentures will join as a board observer.
10x Genomics, a company focused on improving and broadening the application of genomic information today announced the close of a $55 million Series C financing. The financing round was led by Fidelity Management & Research Company and included additional new investors Softbank and JS Capital Management LLC, alongside founding investors Venrock, Foresite Capital, and Paladin Capital.
HealthTell, Inc. announced today the successful close of their Series B financing. Since their incorporation in 2012, HealthTell has been laying the groundwork for a series of next-generation diagnostic tests.
PhishMe’s Rohyt Belani Honored as a CEO of the Year in Info Security Products Guide’s 2016 Global Excellence Awards
PhishMe® Inc., the leading provider of human phishing defense solutions, today announced that CEO and co-founder Rohyt Belani has been honored as a “CEO of the Year” category winner of the 2016 Info Security Products Guide Global Excellence Awards®.
Accenture (NYSE: ACN) formed a new alliance relationship with Endgame Inc. – a provider of cybersecurity software solutions to actively hunt adversaries – to integrate the company’s sophisticated capabilities with Accenture’s cyber defense services. As part of the relationship, Accenture has also taken an equity position in Endgame. Terms of the investment were not disclosed.
By Sir David Omand First published in the World Policy Journal Winter 2015/2016 LONDON—In 1910, one of the last remaining bands of outlaws of America’s Wild West emerged from their hideout in the Sierra Ladrones Mountains in New Mexico and …